Systemic leukocyte filtration during cardiopulmonary bypass

Perfusion

Volumn 16, Issue SUPPL., 2001, Pages 11-18

  Fabbri, A ^a   Manfredi, J ^a   Piccin, C ^a   Soffiati, G ^a   Carta, M R ^a   Gasparotto, E ^a   Nardon, G ^a  

^a Hospital S Bartolo   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE; HEMOGLOBIN; INTERLEUKIN 8; OXYGEN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ADULT; AGE; AGED; AORTA CLAMPING; ARTERIAL GAS; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD ANALYSIS; BLOOD CELL COUNT; BLOOD FILTRATION; BLOOD SAMPLING; BODY HEIGHT; BODY SURFACE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COOLING; CORONARY ARTERY BYPASS GRAFT; EXTRACORPOREAL CIRCULATION; FEMALE; FILTER; GENDER; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT ATRIUM; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; INTUBATION; LABORATORY TEST; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOPENIA; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; NEUTROPHIL; OPERATION DURATION; PATHOGENESIS; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TEMPERATURE; TREATMENT OUTCOME; AGE DISTRIBUTION; BLOOD OXYGEN TENSION; BODY WEIGHT; HEMOGLOBIN BLOOD LEVEL; LEUKOCYTE COUNT; LEUKOCYTE FILTRATION; NEUTROPHIL COUNT; PREOPERATIVE EVALUATION; RANDOM SAMPLE; SEX DIFFERENCE;

EID: 0035050308     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910101600i103     Document Type: Article

References (25)

1. Complement and the damaging effects of cardiopulmonary bypass
2. Respiratory dysfunction after uncomplicated cardiopulmonary bypass
3. Systemic complement activation, lung injury, and products of lipid peroxidation
4. Complement activation before, during and after cardiopulmonary bypass
5. Complement activation during cardiopulmonary bypass
6. Complement activation and lung permeability during cardiopulmonary bypass
7. The role of leucocytes in the systemic inflammatory response and the potential impact of leucocyte depletion
8. Inflammatory response to cardiopulmonary bypass
9. Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass
10. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass
11. Twelve-hour cardiopulmonary preservation using donor core cooling, leukocyte depletion and liposomal superoxide dismutase
12. Leukocyte depletion results in excellent heart-lung function after 12 hours of storage
13. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: A clinical study
14. Clinical evaluation of Leukoguard (LG-6) arterial line filter for routine open-heart surgery
15. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery
16. Laboratory evaluation of the Pall LG6 leukocyte depleting arterial line filter
17. Studies of the effect of Pall leukocyte filters LG6 and AV6 in an in vitro simulated extracorporeal circulatory system
18. Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit
19. Prospects for undertending and eliminating the deleterious effects of cardiopulmonary bypass
20. Plasma levels of main granulocyte components during cardiopulmonary bypass
21. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans
22. Effects of cardiopulmonary bypass on systemic release of neutrophil elastase and tumour necrosis factor
23. Leucocyte depletion during cardiac operation: A new appraoch through the venous bypass circuit
24. An expanded definition of the adult respiratory distress syndrome
25. Use of leucocyte depleting arterial line filter during deep hypothermic cardiopulmonary bypass and circulatory arrest: Correlation with pulmonary function